RE:RE:RE:RE:RE:RE:RE:I sense displeasure ...Wag, since you are so smart, and I am not, how much $$$ did GBT earned/profits in the last quarter. In the last Year
how many new drug licences has GBT and GUD got?
Unless GUD and GBT get scores/dozens of new small drugs and or large moving needle blockbuster new drug licence these two ponies are not going anywhere. The market so far has written GBT off. At this pace of drug licencing forget grandkids investing and think more five generation. Where are the new drug deals and why they are not getting them is the real question. So we can conclude that either MNGT is not comptent to get new deals or there are no new deals to get and thus GUD MNGT business plan is deeply flawed